EGFR and lung carcinoma: Eftekhari-Sis et al. successfully used this technique to detect exon 19 deletions in the estimated Glomerular filtration rate (EGFR) gene, which is a gene mutation that plays a very important role in lung cancer and is used clinically to evaluate the use of targeted drugs in patients with non-small cell lung cancer (Figure 2D) [90].